Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Taiwan - Delayed Quote TWD

OK Biotech Co., Ltd. (4155.TW)

Compare
19.00
-0.05
(-0.26%)
At close: April 2 at 1:30:22 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Chia-De Lai General Manager, MD & Chairman of the Board -- -- --
Qi Zheng Hou CFO, Financial Manager, Accounting Supervisor & Director -- -- --
De Quan Zhang Chief Operating Officer, Deputy General Manager, Director -- -- --
De Zhao Wang Business Office Associate, Director -- -- --

OK Biotech Co., Ltd.

No. 91, Gongdao 5th Road
Section 2
Hsinchu City, 30070
Taiwan
886 3 516 0258 https://www.okbiotech.com
Sector: 
Healthcare
Industry: 
Medical Devices

Description

OK Biotech Co., Ltd. develops, manufactures, markets, and sells blood glucose monitoring devices and related homecare medical products in Taiwan and internationally. It also provides glucometers and blood glucose test strips; nebulizer, portable nebulizer, mesh nebulizer, and test strips; and personal sound amplifiers. OK Biotech Co., Ltd. was founded in 2006 and is headquartered in Hsinchu City, Taiwan.

Corporate Governance

OK Biotech Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

April 30, 2025 at 10:59 AM UTC - May 5, 2025 at 12:00 PM UTC

OK Biotech Co., Ltd. Earnings Date

Recent Events

September 5, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers